Stock screener

BBNX

Conviction 59HealthcareScan · Thu, Jun 25, 2026
BBNX$15.90+7.94%
ResistanceSupportVol 14Insider sell
63 bars
2
2
5
2
Vol MA14 1.15M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Beta Bionics, Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.betabionics.com
Price15.90
Change+7.94%
Gap-0.68%
Rel volume1.51×
Avg volume1.05M
Avg $ vol14.67M
SMA 2013.73
SMA 5011.95
SMA 20018.34
Price vs 50+33.05%
Price vs 200-13.30%
MA stackmixed
50/200 cross
Supertrendup · 12.40
RSI (14)71
MACD hist0.05
MACD crossbull · 0d
Stoch %K / %D80 / 73
ADX (14)35
+DI / −DI33 / 9
RSI divergence
MACD divergence
ATR %+6.40%
ADR %7.33%
52w high31.99
52w low8.86
From 52w high-50.30%
Above 52w low+79.46%
New 52w highNo
SqueezeOff
Bollinger width27.01%
%B1.08
Donchian pos86.12%
Donchian high16.63
Donchian low11.37
AVWAP (52w high)16.09
vs AVWAP high-1.15%
AVWAP (52w low)12.12
vs AVWAP low+31.22%
OBV trendFlat
Chaikin MF (20)0.09
Today vs 20d1.51×
Avg vol (14d)1.15M
Avg vol (20d)1.05M
Avg $ vol (20d)14.67M
Market cap708.53M
RS 3m (vs SPY)+18.79%
RS 6m (vs SPY)-57.38%
RS line new highYes
Trend template3/8
Technical rank46.3
1 week+20.55%
1 month+35.67%
3 months+40.58%
6 months-49.83%
1 year+1.15%
YTD-45.64%
P/E-9.68
P/B2.61
P/S7.07
P/FCF-12.60
EPS-1.81
Div yield
ROE-26.99%
ROA-24.05%
Debt/Eq
Current10.69
EV/EBITDA
Gross margin55.40%
Net margin-73.02%
Rev growth53.94%
EPS growth-33.68%
Price target17.67
Target upside11.13%
Analyst ratingBuy
Institutional117.00%
Ent. value678.32M
Revenue27.63M
Net income-21.89M
Gross profit16.44M
Free cash flow-56.22M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out44.56M
Employees423
ListedThu, Jan 30, 2025
Free float37.66M
Float %84.8%
Short interest5.2M
Days to cover7.2d
Short volume39.3%
Squeeze score60 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.62 · 4 est
Last EPS vs est−$0.49 vs −$0.53
Last surprise+7.5% beat
Setup gradeC
Conviction59 / 100
Pattern quality
Tech rank46.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance14.94
Support9.45
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BBNX

All disclosures →
No recent disclosed trades by Congress in BBNX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BBNX · 10 sells

InsiderSideShares
Hopman Mark
Chief Commercial Officer · Common Stock · 2026-06-24
Sell1.26K
Jones Christy
Director · Common Stock · 2026-06-24
Sell1.41K
Hopman Mark
Chief Commercial Officer · Common Stock · 2026-06-04
Sell275
Jones Christy
Director · Common Stock · 2026-06-04
Sell2.81K
Hopman Mark
Chief Commercial Officer · Common Stock · 2026-06-02
Sell5.33K
Mensinger Mike
Chief Product Officer · Common Stock · 2026-06-02
Sell4.38K
Russell Steven Jon
Chief Medical Officer · Common Stock · 2026-06-02
Sell4.22K
Feider Stephen
Chief Financial Officer · Common Stock · 2026-06-02
Sell6.68K
Saint Sean
President & CEO · Common Stock · 2026-06-02
Sell16.87K
Lezack Adam
Director · Comon Stock · 2026-05-22
Sell998

SEC filings

EDGAR filings in BBNX · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.